Loading...

Jody Corey-Bloom

TitleEmeritus Professor
InstitutionUniversity of California San Diego
DepartmentNeurosciences
Address9500 Gilman Drive #0948
La Jolla CA 92093
Phone858-246-1288
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    UCSD Alzheimer's Disease Research Center P50
    NIH/NIA P50AG005131Sep 28, 1984 - Mar 31, 2019
    Role: Co-Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000827Mar 1, 1974 - Nov 30, 2010
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Corey-Bloom J, Haque AS, Park S, Nathan AS, Baker RW, Thomas EA. Salivary levels of total huntingtin are elevated in Huntington's disease patients. Sci Rep. 2018 May 09; 8(1):7371. PMID: 29743609.
      View in: PubMed
    2. Graves LV, Van Etten EJ, Holden HM, Delano-Wood L, Bondi MW, Corey-Bloom J, Delis DC, Gilbert PE. Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Aug 31; 1-16. PMID: 28857679.
      View in: PubMed
    3. Doyle KL, Woods SP, McDonald CR, Leyden KM, Holden HM, E Morgan E, Gilbert PE, Corey-Bloom J. Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy. Appl Neuropsychol Adult. 2017 Aug 29; 1-11. PMID: 28850256.
      View in: PubMed
    4. Corey-Bloom J, Aikin AM, Gutierrez AM, Nadhem JS, Howell TL, Thomas EA. Beneficial effects of glatiramer acetate in Huntington's disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms. Brain Res. 2017 Oct 15; 1673:102-110. PMID: 28823953.
      View in: PubMed
    5. Sheth VR, Fan S, He Q, Ma Y, Annese J, Switzer R, Corey-Bloom J, Bydder GM, Du J. Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - A feasibility study. Magn Reson Imaging. 2017 05; 38:87-94. PMID: 28038965.
      View in: PubMed
    6. Van Liew C, Santoro MS, Goldstein J, Gluhm S, Gilbert PE, Corey-Bloom J. Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases. Am J Alzheimers Dis Other Demen. 2016 Dec; 31(8):658-663. PMID: 27678491.
      View in: PubMed
    7. Graves LV, Holden HM, Delano-Wood L, Bondi MW, Woods SP, Corey-Bloom J, Salmon DP, Delis DC, Gilbert PE. Total recognition discriminability in Huntington's and Alzheimer's disease. J Clin Exp Neuropsychol. 2017 Mar; 39(2):120-130. PMID: 27441951.
      View in: PubMed
    8. Sheth V, Shao H, Chen J, Vandenberg S, Corey-Bloom J, Bydder GM, Du J. Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies. Neuroimage. 2016 Aug 01; 136:37-44. PMID: 27155128; PMCID: PMC4914437 [Available on 08/01/17].
    9. Sheppard DP, Pirogovsky-Turk E, Woods SP, Holden HM, Nicoll DR, Filoteo JV, Corey-Bloom J, Gilbert PE. Everyday Functioning in Huntington's Disease: A Laboratory-Based Study of Financial Management Capacity. Appl Neuropsychol Adult. 2017 Mar-Apr; 24(2):176-182. PMID: 27077945.
      View in: PubMed
    10. Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Loredo JS, Ancoli-Israel S. Obstructive Sleep Apnea and Cognition in Parkinson's disease. Sleep Med. 2016 05; 21:28-34. PMID: 27448468.
      View in: PubMed
    11. Corey-Bloom J, Gluhm S, Herndon A, Haque AS, Park S, Gilbert PE. Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease. J Huntingtons Dis. 2016; 5(1):91-6. PMID: 27003664.
      View in: PubMed
    12. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol. 2016 Jan; 73(1):102-10. PMID: 26569098.
      View in: PubMed
    13. Du J, Sheth V, He Q, Carl M, Chen J, Corey-Bloom J, Bydder GM. Measurement of T1 of the ultrashort T2* components in white matter of the brain at 3T. PLoS One. 2014; 9(8):e103296. PMID: 25093859; PMCID: PMC4122467.
    14. Hall CA, Reynolds CF, Butters M, Zisook S, Simon N, Corey-Bloom J, Lebowitz BD, Begley A, Mauro C, Shear MK. Cognitive functioning in complicated grief. J Psychiatr Res. 2014 Nov; 58:20-5. PMID: 25088285; PMCID: PMC4163517.
    15. Neikrug AB, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Med. 2014 Aug; 15(8):959-66. PMID: 24938585; PMCID: PMC4117926.
    16. Neikrug AB, Liu L, Avanzino JA, Maglione JE, Natarajan L, Bradley L, Maugeri A, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea. Sleep. 2014 Jan 01; 37(1):177-85. PMID: 24470706; PMCID: PMC3902881.
    17. Corey-Bloom J, Jia H, Aikin AM, Thomas EA. Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease. J Huntingtons Dis. 2014; 3(3):311-6. PMID: 25300334; PMCID: PMC4480978.
    18. Nicoll DR, Pirogovsky E, Woods SP, Holden HM, Filoteo JV, Gluhm S, Corey-Bloom J, Gilbert PE. "Forgetting to remember" in Huntington's disease: a study of laboratory, semi-naturalistic, and self-perceptions of prospective memory. J Int Neuropsychol Soc. 2014 Feb; 20(2):192-9. PMID: 24351166.
      View in: PubMed
    19. Pirogovsky E, Nicoll DR, Challener DM, Breen E, Gluhm S, Corey-Bloom J, Gilbert PE. The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease. J Neuropsychol. 2015 Mar; 9(1):77-86. PMID: 24330469.
      View in: PubMed
    20. Neikrug AB, Maglione JE, Liu L, Natarajan L, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Effects of sleep disorders on the non-motor symptoms of Parkinson disease. J Clin Sleep Med. 2013 Nov 15; 9(11):1119-29. PMID: 24235892; PMCID: PMC3805796.
    21. Du J, Ma G, Li S, Carl M, Szeverenyi NM, VandenBerg S, Corey-Bloom J, Bydder GM. Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner. Neuroimage. 2014 Feb 15; 87:32-41. PMID: 24188809; PMCID: PMC4091919.
    22. Majid DS, Cai W, Corey-Bloom J, Aron AR. Proactive selective response suppression is implemented via the basal ganglia. J Neurosci. 2013 Aug 14; 33(33):13259-69. PMID: 23946385; PMCID: PMC3742918.
    23. Maglione JE, Liu L, Neikrug AB, Poon T, Natarajan L, Calderon J, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Actigraphy for the assessment of sleep measures in Parkinson's disease. Sleep. 2013 Aug 01; 36(8):1209-17. PMID: 23904681; PMCID: PMC3700718.
    24. Gluhm S, Goldstein J, Brown D, Van Liew C, Gilbert PE, Corey-Bloom J. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease. Mov Disord. 2013 Oct; 28(12):1744-7. PMID: 23798501; PMCID: PMC4347861.
    25. Sherzai A, Edland SD, Masliah E, Hansen L, Pizzo DP, Sherzai A, Corey-Bloom J. Spongiform change in dementia with Lewy bodies and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013 Apr-Jun; 27(2):157-61. PMID: 22546782.
      View in: PubMed
    26. Gluhm S, Goldstein J, Loc K, Colt A, Liew CV, Corey-Bloom J. Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cogn Behav Neurol. 2013 Mar; 26(1):1-5. PMID: 23538566; PMCID: PMC3638088.
    27. Van Liew C, Gluhm S, Goldstein J, Cronan TA, Corey-Bloom J. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease. Psychiatry. 2013; 76(4):323-35. PMID: 24299091.
      View in: PubMed
    28. Medina LD, Pirogovsky E, Salomonczyk D, Goldstein J, Panzera R, Gluhm S, Simmons R, Corey-Bloom J, Gilbert PE. Postural limits of stability in premanifest and manifest Huntington's disease. J Huntingtons Dis. 2013; 2(2):177-84. PMID: 25063514.
      View in: PubMed
    29. Nicoll DR, Pirogovsky E, Collazo AE, Tierney SM, Corey-Bloom J, Gilbert PE. The effect of interference on temporal order memory in premanifest and manifest Huntington's disease. J Huntingtons Dis. 2013; 2(3):297-304. PMID: 25062677; PMCID: PMC4116086.
    30. Mickes L, Wixted JT, Peavy GM, Jacobson MW, Goldstein JL, Corey-Bloom J. Difficulty modifying a sustained motor response in prodromal Huntington's disease. J Clin Exp Neuropsychol. 2013; 35(1):35-40. PMID: 23198997.
      View in: PubMed
    31. Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS, Helmers SL, Factor SA, Jones R, Testa CM. Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort. Mov Disord. 2012 Dec; 27(14):1797-800. PMID: 23124580.
      View in: PubMed
    32. Covassin N, Neikrug AB, Liu L, Maglione J, Natarajan L, Corey-Bloom J, Loredo JS, Palmer BW, Redwine LS, Ancoli-Israel S. Relationships between clinical characteristics and nocturnal cardiac autonomic activity in Parkinson's disease. Auton Neurosci. 2012 Nov 02; 171(1-2):85-8. PMID: 23141523; PMCID: PMC3501606.
    33. Lessig S, Nie D, Xu R, Corey-Bloom J. Changes on brief cognitive instruments over time in Parkinson's disease. Mov Disord. 2012 Aug; 27(9):1125-8. PMID: 22692724.
      View in: PubMed
    34. Pillai JA, Hansen LA, Masliah E, Goldstein JL, Edland SD, Corey-Bloom J. Clinical severity of Huntington's disease does not always correlate with neuropathologic stage. Mov Disord. 2012 Aug; 27(9):1099-103. PMID: 22674458; PMCID: PMC3412903.
    35. Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ. 2012 Jul 10; 184(10):1143-50. PMID: 22586334; PMCID: PMC3394820.
    36. Covassin N, Neikrug AB, Liu L, Corey-Bloom J, Loredo JS, Palmer BW, Maglione J, Ancoli-Israel S. Clinical correlates of periodic limb movements in sleep in Parkinson's disease. J Neurol Sci. 2012 May 15; 316(1-2):131-6. PMID: 22277375; PMCID: PMC3321115.
    37. Corey-Bloom J. Treatment trials in aging and mild cognitive impairment. Curr Top Behav Neurosci. 2012; 10:347-56. PMID: 21786037.
      View in: PubMed
    38. Majid DS, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation. Mov Disord. 2011 Dec; 26(14):2544-51. PMID: 21932302.
      View in: PubMed
    39. Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB. Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease. Neuroimage. 2012 Feb 01; 59(3):2452-63. PMID: 21945695; PMCID: PMC3254727.
    40. Turner TH, Goldstein J, Hamilton JM, Jacobson M, Pirogovsky E, Peavy G, Corey-Bloom J. Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease. J Mot Behav. 2011; 43(4):295-302. PMID: 21774606; PMCID: PMC3568932.
    41. Majid DS, Stoffers D, Sheldon S, Hamza S, Thompson WK, Goldstein J, Corey-Bloom J, Aron AR. Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year. Mov Disord. 2011 Jul; 26(8):1481-8. PMID: 21484871; PMCID: PMC3136652.
    42. Panzera R, Salomonczyk D, Pirogovosky E, Simmons R, Goldstein J, Corey-Bloom J, Gilbert PE. Postural deficits in Huntington's disease when performing motor skills involved in daily living. Gait Posture. 2011 Mar; 33(3):457-61. PMID: 21256027.
      View in: PubMed
    43. Salomonczyk D, Panzera R, Pirogovosky E, Goldstein J, Corey-Bloom J, Simmons R, Gilbert PE. Impaired postural stability as a marker of premanifest Huntington's disease. Mov Disord. 2010 Oct 30; 25(14):2428-33. PMID: 20818666.
      View in: PubMed
    44. Mickes L, Jacobson M, Peavy G, Wixted JT, Lessig S, Goldstein JL, Corey-Bloom J. A comparison of two brief screening measures of cognitive impairment in Huntington's disease. Mov Disord. 2010 Oct 15; 25(13):2229-33. PMID: 20721924.
      View in: PubMed
    45. Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J. Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Mov Disord. 2010 Jul 15; 25(9):1163-9. PMID: 20629124; PMCID: PMC2910142.
    46. Rizk-Jackson A, Stoffers D, Sheldon S, Kuperman J, Dale A, Goldstein J, Corey-Bloom J, Poldrack RA, Aron AR. Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques. Neuroimage. 2011 May 15; 56(2):788-96. PMID: 20451620.
      View in: PubMed
    47. Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, Seely L, Walker F, Feigin A. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Arch Neurol. 2010 Feb; 67(2):154-60. PMID: 20142523; PMCID: PMC4134015.
    48. Cooke JR, Ancoli-Israel S, Liu L, Loredo JS, Natarajan L, Palmer BS, He F, Corey-Bloom J. Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea. Sleep Med. 2009 Dec; 10(10):1101-6. PMID: 19699148; PMCID: PMC2783482.
    49. Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med. 2009 Aug 15; 5(4):305-9. PMID: 19968005; PMCID: PMC2725246.
    50. Pirogovsky E, Goldstein J, Peavy G, Jacobson MW, Corey-Bloom J, Gilbert PE. Temporal order memory deficits prior to clinical diagnosis in Huntington's disease. J Int Neuropsychol Soc. 2009 Sep; 15(5):662-70. PMID: 19635179.
      View in: PubMed
    51. Jak AJ, Urban S, McCauley A, Bangen KJ, Delano-Wood L, Corey-Bloom J, Bondi MW. Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc. 2009 Nov; 15(6):890-7. PMID: 19570306; PMCID: PMC2864786.
    52. Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry. 2009 May; 17(5):368-75. PMID: 19390294; PMCID: PMC2743175.
    53. Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom J, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement. 2009 Mar; 5(2):85-92. PMID: 19328434; PMCID: PMC3959165.
    54. Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry. 2009 Feb; 17(2):166-9. PMID: 19155748; PMCID: PMC2630117.
    55. Jak AJ, Bangen KJ, Wierenga CE, Delano-Wood L, Corey-Bloom J, Bondi MW. Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. Int Rev Neurobiol. 2009; 84:81-103. PMID: 19501714; PMCID: PMC2864107.
    56. Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J Am Geriatr Soc. 2008 Nov; 56(11):2076-81. PMID: 18795985; PMCID: PMC2585146.
    57. Marcotte TD, Rosenthal TJ, Roberts E, Lampinen S, Scott JC, Allen RW, Corey-Bloom J. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Arch Phys Med Rehabil. 2008 Sep; 89(9):1753-8. PMID: 18760160; PMCID: PMC4560356.
    58. Fine EM, Delis DC, Wetter SR, Jacobson MW, Hamilton JM, Peavy G, Goldstein J, McDonald C, Corey-Bloom J, Bondi MW, Salmon DP. Identifying the "source" of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: evidence from the CVLT-II. J Clin Exp Neuropsychol. 2008 May; 30(4):463-70. PMID: 18415887; PMCID: PMC2864091.
    59. Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs Aging. 2008; 25(2):163-74. PMID: 18257603.
      View in: PubMed
    60. Pirogovsky E, Gilbert PE, Jacobson M, Peavy G, Wetter S, Goldstein J, Corey-Bloom J, Murphy C. Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease. J Clin Exp Neuropsychol. 2007 May; 29(4):395-404. PMID: 17497563.
      View in: PubMed
    61. Jak AJ, Houston WS, Nagel BJ, Corey-Bloom J, Bondi MW. Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dement Geriatr Cogn Disord. 2007; 23(6):382-9. PMID: 17389798; PMCID: PMC2084479.
    62. Yaari R, Corey-Bloom J. Alzheimer's disease. Semin Neurol. 2007 Feb; 27(1):32-41. PMID: 17226739.
      View in: PubMed
    63. Chong MS, Ayalon L, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Liu L, Ancoli-Israel S. Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer's disease with sleep disordered breathing. J Am Geriatr Soc. 2006 May; 54(5):777-81. PMID: 16696743.
      View in: PubMed
    64. Ayalon L, Ancoli-Israel S, Stepnowsky C, Marler M, Palmer BW, Liu L, Loredo JS, Corey-Bloom J, Greenfield D, Cooke J. Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. Am J Geriatr Psychiatry. 2006 Feb; 14(2):176-80. PMID: 16473983.
      View in: PubMed
    65. Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging. 2007 Feb; 28(2):238-47. PMID: 16434125; PMCID: PMC1705815.
    66. Tiraboschi P, Salmon DP, Hansen LA, Hofstetter RC, Thal LJ, Corey-Bloom J. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain. 2006 Mar; 129(Pt 3):729-35. PMID: 16401618.
      View in: PubMed
    67. Cooke JR, Liu L, Natarajan L, He F, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Greenfield D, Ancoli-Israel S. The effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer's disease. Behav Sleep Med. 2006; 4(4):219-27. PMID: 17083302.
      View in: PubMed
    68. Cooke JR, Loredo JS, Liu L, Marler M, Corey-Bloom J, Fiorentino L, Harrison T, Ancoli-Israel S. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs Aging. 2006; 23(6):503-11. PMID: 16872233.
      View in: PubMed
    69. Polich J, Corey-Bloom J. Alzheimer's disease and P300: review and evaluation of task and modality. Curr Alzheimer Res. 2005 Dec; 2(5):515-25. PMID: 16375655.
      View in: PubMed
    70. Delis DC, Wetter SR, Jacobson MW, Peavy G, Hamilton J, Gongvatana A, Kramer JH, Bondi MW, Corey-Bloom J, Salmon DP. Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia. J Int Neuropsychol Soc. 2005 Oct; 11(6):708-15. PMID: 16248906.
      View in: PubMed
    71. Brodaty H, Corey-Bloom J, Potocnik FC, Truyen L, Gold M, Damaraju CR. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. Dement Geriatr Cogn Disord. 2005; 20(2-3):120-32. PMID: 15990426.
      View in: PubMed
    72. Gehrman P, Marler M, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. The relationship between dementia severity and rest/activity circadian rhythms. Neuropsychiatr Dis Treat. 2005 Jun; 1(2):155-63. PMID: 18568061; PMCID: PMC2413196.
    73. Lineweaver TT, Salmon DP, Bondi MW, Corey-Bloom J. Differential effects of Alzheimer's disease and Huntington's disease on the performance of mental rotation. J Int Neuropsychol Soc. 2005 Jan; 11(1):30-9. PMID: 15686606.
      View in: PubMed
    74. Gehrman P, Marler M, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. The timing of activity rhythms in patients with dementia is related to survival. J Gerontol A Biol Sci Med Sci. 2004 Oct; 59(10):1050-5. PMID: 15528777.
      View in: PubMed
    75. Gehrman PR, Martin JL, Shochat T, Nolan S, Corey-Bloom J, Ancoli-Israel S. Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease. Am J Geriatr Psychiatry. 2003 Jul-Aug; 11(4):426-33. PMID: 12837671.
      View in: PubMed
    76. Bondi MW, Houston WS, Salmon DP, Corey-Bloom J, Katzman R, Thal LJ, Delis DC. Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores. J Int Neuropsychol Soc. 2003 Jul; 9(5):783-95. PMID: 12901784; PMCID: PMC1621043.
    77. Ancoli-Israel S, Martin JL, Gehrman P, Shochat T, Corey-Bloom J, Marler M, Nolan S, Levi L. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry. 2003 Mar-Apr; 11(2):194-203. PMID: 12611749.
      View in: PubMed
    78. Ancoli-Israel S, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi L. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med. 2003; 1(1):22-36. PMID: 15600135.
      View in: PubMed
    79. Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry. 2002 Oct; 59(10):946-51. PMID: 12365882.
      View in: PubMed
    80. Corey-Bloom J. The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias. Int Psychogeriatr. 2002; 14 Suppl 1:51-75. PMID: 12636180.
      View in: PubMed